News and Opinions - World Stem Cell Summit

Common Viruses May Be Triggering the Onset of Alzheimer’s Disease

by admin | Sep 21, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Shingles infection may activate dormant neurological herpes viruses, causing inflammation and accumulation of Alzheimer’s associated proteins in the brain by Mike Silver – TuftsNow Alzheimer’s disease can begin almost imperceptibly, often masquerading in the...

After last year’s public rejection, BrainStorm to give ALS cell therapy another shot

by admin | Sep 20, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Tyler Patchen and Kyle LaHucik – EndpointsNews Above image caption: Chaim Lebovits, BrainStorm CEO After a rare public rejection from the FDA last year, BrainStorm Cell Therapeutics is headed back to the regulator with what it claims is a “correction” to...

A research partnership brings gene editing promise to eye disease

by admin | Sep 19, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Brian Mattmiller In order to tap the tremendous potential of CRISPR gene editing technology for reversing human disease, Wisconsin scientists are working with a star pupil. The human eye — though one of the body’s most complex and intricate structures — happens to...

Could Stem-Cell Based Therapy Treat Type-1 Diabetes? A New Study Demonstrates the Treatment’s Potential

by admin | Sep 18, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By The Endocrine Society The findings suggest stem cell-based replacement therapy has the potential to manage blood sugar levels and may eventually replace the requirement for external insulin injections or dosing. Stem-cell therapy has promise in the treatment of...

Pioneering stem-cell trials in Japan report promising early results

by admin | Sep 17, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

The country has invested hundreds of millions of dollars into research on induced pluripotent stem cells to treat diseased organs. by: Smriti Mallapaty – Nature Some of the first trials to test whether reprogrammed stem cells can repair diseased organs have...

Moderna sues Pfizer, BioNTech over COVID-19 vaccine

by admin | Sep 12, 2022 | News and Opinions

Moderna is suing Pfizer and BioNTech, alleging they copied technology that Moderna first developed years before the pandemic in producing the first COVID-19 vaccine approved in the U.S., the company announced Friday. Driving the news: Moderna is seeking unspecified...